GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline
Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue feedstocks (for example wheat straw and wood chips) into renewable gasoline. Another workpackage is dedicated to the preparation of the path to commercialization with third parties. Shipment of a renewable gasoline batch to Audi is also part of the program in order to perform further engine testing.
Marc Delcourt, CEO of Global Bioenergies, states: "Our renewable gasoline combines a global environmental benefit, namely CO2 savings, with the reduction of particles formed in the combustion chambers. Thus such product is an interesting solution to cope with the Paris GHG targets and the severe emission limitations for passenger cars."
Global Bioenergies' renewable gasoline can be blended in high proportion (over 30%) into fossil gasoline. The mix is suitable for any gasoline engine and therefore interoperable with existing car fleets, without any need for modification. Its large scale commercialization will not require any specific storage nor distribution infrastructure, thus creating an efficient option for countries in their efforts to meet their CO2 reduction targets, and for cities willing to improve their air quality.
Reiner Mangold, head of sustainable product development at Audi, adds: "The recent developments at Global Bioenergies support our vision that e-gasoline might be a game changer in the objective to reduce the GHG emissions in the transport sector in a fast and complete way."
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market
Evotec expands collaboration with MedImmune, receives milestone payment

Water-Soluble Warped Nanographene - Synthesis of a water-soluble warped nanographene and its application for photo-induced cell death

Photoswitchable Bactericide - Nanomaterial with “Light Switch” Kills Gram-negative or Gram-positive Bacteria
Diastole
